Quarterly report · Q2

Period2023-04-01 → 2023-09-30
Filed2023-11-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥10.5bn2023-04-01 → 2023-09-30Cons.Net sales
Revenue¥18.0bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥9.1bn2022-04-01 → 2022-09-30Cons.Net sales
Operating income¥1.7bn2023-04-01 → 2023-09-30Cons.Operating income
Operating income¥1.2bn2022-04-01 → 2022-09-30Cons.Operating income
Ordinary income¥1.8bn2023-04-01 → 2023-09-30Cons.Ordinary income
Ordinary income¥2.5bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥1.3bn2022-04-01 → 2022-09-30Cons.Ordinary income
Profit before tax¥1.8bn2023-04-01 → 2023-09-30Cons.Income before income taxes
Profit before tax¥1.3bn2022-04-01 → 2022-09-30Cons.Income before income taxes
Net income (owners)¥1.2bn2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥1.6bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥848m2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income¥1.2bn2023-04-01 → 2023-09-30Cons.Profit loss
Net income¥926m2022-04-01 → 2022-09-30Cons.Profit loss
Total assets¥30.1bnat 2023-09-30Cons.Assets
Total assets¥29.0bnat 2023-03-31Cons.Assets
Total assets¥27.5bnat 2022-09-30Cons.Total assets (5-year summary)
Total liabilities¥7.5bnat 2023-09-30Cons.Liabilities
Total liabilities¥6.9bnat 2023-03-31Cons.Liabilities
Net assets / equity¥22.5bnat 2023-09-30Cons.Net assets
Net assets / equity¥22.1bnat 2023-03-31Cons.Net assets
Net assets / equity¥21.4bnat 2022-09-30Cons.Net assets (5-year summary)
Cash and deposits¥13.3bnat 2023-09-30Cons.Cash and deposits
Cash and deposits¥12.8bnat 2023-03-31Cons.Cash and deposits
Cash & equivalents¥13.3bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥12.8bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥12.9bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥11.9bnat 2022-03-31dCons.Cash and cash equivalents
Operating cash flow¥1.5bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥1.9bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥1.2bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥149m2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥551m2022-04-01 → 2023-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow¥232m2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥985m2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥500m2022-04-01 → 2023-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥486m2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥155.762023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥100.272023-07-01 → 2023-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥214.782022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥110.62022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥67.942022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio71.0%at 2023-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio72.4%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio73.7%at 2022-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 18
SegmentItemPeriodValue
jpcrp040300-q2r_E02333-000Medical Relatedreportable segmentrevenue2023-04-01 → 2023-09-30¥1.3bn
jpcrp040300-q2r_E02333-000Medical Relatedreportable segmentrevenue external2023-04-01 → 2023-09-30¥1.3bn
jpcrp040300-q2r_E02333-000Medical Relatedreportable segmentsegment profit2023-04-01 → 2023-09-30¥194m
jpcrp040300-q2r_E02333-000Water Health Carereportable segmentrevenue2023-04-01 → 2023-09-30¥9.2bn
jpcrp040300-q2r_E02333-000Water Health Carereportable segmentrevenue external2023-04-01 → 2023-09-30¥9.2bn
jpcrp040300-q2r_E02333-000Water Health Carereportable segmentsegment profit2023-04-01 → 2023-09-30¥1.5bn
—segment totalrevenue2023-04-01 → 2023-09-30¥10.5bn
—segment totalrevenue external2023-04-01 → 2023-09-30¥10.5bn
—segment totalsegment profit2023-04-01 → 2023-09-30¥1.7bn
jpcrp040300-q2r_E02333-000Medical Relatedreportable segmentrevenue2022-04-01 → 2022-09-30¥1.2bn
jpcrp040300-q2r_E02333-000Medical Relatedreportable segmentrevenue external2022-04-01 → 2022-09-30¥1.2bn
jpcrp040300-q2r_E02333-000Medical Relatedreportable segmentsegment profit2022-04-01 → 2022-09-30¥138m
jpcrp040300-q2r_E02333-000Water Health Carereportable segmentrevenue2022-04-01 → 2022-09-30¥7.9bn
jpcrp040300-q2r_E02333-000Water Health Carereportable segmentrevenue external2022-04-01 → 2022-09-30¥7.9bn
jpcrp040300-q2r_E02333-000Water Health Carereportable segmentsegment profit2022-04-01 → 2022-09-30¥1.1bn
—segment totalrevenue2022-04-01 → 2022-09-30¥9.1bn
—segment totalrevenue external2022-04-01 → 2022-09-30¥9.1bn
—segment totalsegment profit2022-04-01 → 2022-09-30¥1.2bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 505
ItemContextValueUnit
Other nclPrior1YearInstant372479000JPY
Other nclCurrentQuarterInstant491937000JPY
Noncurrent liabilitiesPrior1YearInstant1012982000JPY
Noncurrent liabilitiesCurrentQuarterInstant1201530000JPY
LiabilitiesPrior1YearInstant6918358000JPY
LiabilitiesCurrentQuarterInstant7510443000JPY
Capital stockPrior1YearInstant992597000JPY
Capital stockCurrentQuarterInstant992597000JPY
Capital surplusPrior1YearInstant1823945000JPY
Capital surplusCurrentQuarterInstant1823945000JPY
Retained earningsPrior1YearInstant21660473000JPY
Retained earningsCurrentQuarterInstant21882624000JPY
Treasury stockPrior1YearInstant-3448032000JPY
Treasury stockCurrentQuarterInstant-3448032000JPY
Shareholders equityPrior1YearInstant21028983000JPY
Shareholders equityCurrentQuarterInstant21251134000JPY
Valuation difference on available for sale securitiesPrior1YearInstant1159000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant18081000JPY
Foreign currency translation adjustmentPrior1YearInstant-89000JPY
Foreign currency translation adjustmentCurrentQuarterInstant74567000JPY
Remeasurements of defined benefit plansPrior1YearInstant-1627000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant-1059000JPY
Valuation and translation adjustmentsPrior1YearInstant-557000JPY
Valuation and translation adjustmentsCurrentQuarterInstant91588000JPY
Non controlling interestsPrior1YearInstant1100196000JPY
Non controlling interestsCurrentQuarterInstant1200475000JPY
Net assetsPrior1YearInstant22128622000JPY
Net assetsCurrentQuarterInstant22543199000JPY
Liabilities and net assetsPrior1YearInstant29046980000JPY
Liabilities and net assetsCurrentQuarterInstant30053642000JPY
Net salesPrior1YTDDuration9081037000JPY
Net salesCurrentYTDDuration10452775000JPY
Cost of salesPrior1YTDDuration2787798000JPY
Cost of salesCurrentYTDDuration3082010000JPY
Gross profitPrior1YTDDuration6293238000JPY
Gross profitCurrentYTDDuration7370764000JPY
Selling general and administrative expensesPrior1YTDDuration5072426000JPY
Selling general and administrative expensesCurrentYTDDuration5684573000JPY
Operating incomePrior1YTDDuration1220812000JPY
Operating incomeCurrentYTDDuration1686191000JPY
Interest and dividends income noiPrior1YTDDuration11192000JPY
Interest and dividends income noiCurrentYTDDuration13591000JPY
Equity in earnings of affiliates noiPrior1YTDDuration3439000JPY
Equity in earnings of affiliates noiCurrentYTDDuration8514000JPY
Real estate rent noiPrior1YTDDuration41230000JPY
Real estate rent noiCurrentYTDDuration41337000JPY
Foreign exchange gains noiPrior1YTDDuration4570000JPY
Foreign exchange gains noiCurrentYTDDuration2865000JPY
Insurance premiums refunded cancellation noiPrior1YTDDuration-JPY
Insurance premiums refunded cancellation noiCurrentYTDDuration5305000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass